Evidence map›Paper›PMID 41767263›Full record

ArticleiScience2026

Identification of multigene predictors of prognosis in patients with ovarian cancer.

Xia Liu, Xiaoying Chen, Lihe Jiang, Yuting Su, Cong Wang, Zhe Du, Sanqi An, Daizheng Huang, Fuqiang Yin

Abstract read
In one paragraph

Article in iScience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Xia LiuKey Laboratory of Longevity and Aging-related Diseases of Chinese Ministry of Education, Institute of Neuroscience and Guangxi Key Laboratory of Brain Science, School of Basic Medical Sciences, Guangxi Medical University, Nanning, Guangxi 530021, P.R. China.
Xiaoying ChenKey Laboratory of Longevity and Aging-related Diseases of Chinese Ministry of Education, Institute of Neuroscience and Guangxi Key Laboratory of Brain Science, School of Basic Medical Sciences, Guangxi Medical University, Nanning, Guangxi 530021, P.R. China.
Lihe JiangSchool of Basic Medical Sciences, Youjiang Medical University for Nationalities, Baise, Guangxi 533000, P.R. China.
Yuting SuLife Sciences Institute, Guangxi Medical University, Nanning, Guangxi 530021, P.R. China.
Cong WangLife Sciences Institute, Guangxi Medical University, Nanning, Guangxi 530021, P.R. China.
Zhe DuLife Sciences Institute, Guangxi Medical University, Nanning, Guangxi 530021, P.R. China.
Sanqi AnLife Sciences Institute, Guangxi Medical University, Nanning, Guangxi 530021, P.R. China.
Daizheng HuangLife Sciences Institute, Guangxi Medical University, Nanning, Guangxi 530021, P.R. China.
Fuqiang YinLife Sciences Institute, Guangxi Medical University, Nanning, Guangxi 530021, P.R. China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The high recurrence and mortality of ovarian cancer (OC) necessitate reliable prognostic tools. As multigene models outperform single-gene markers, they are crucial for advancing clinical decision-making. From 4 microarray datasets (N = 859) and a large OC cohort (N = 1793), we identified 87 overall survival (OS)- and/or progression-free survival (PFS)-associated genes. Multigene models revealed that 25 combinations and 5 combinations predicted at least 5-year OS and 5-year PFS, respectively. Notably, compared with all combinations of 4 randomly selected genes, combinations involving

Indexed as

health scienceshealth technologymedicineoncology

Identifiers

PMID41767263
PMCPMC12936820

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.